Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cartosense is an Indian medical technology company developing surgical navigation systems for operating rooms, with an emphasis on neurosurgery and other precision procedures. The company combines proprietary optical tracking hardware, navigation software, AR/VR-related technology, and AI-enabled image-to-anatomy mapping to help surgeons localize anatomy and instruments more accurately during surgery. Its lead commercial product is the CDSCO-approved C75 Surgical Navigation System, which is designed to improve line-of-sight tracking, simplify setup, and support flexible patient positioning in the operating theatre. Cartosense appears to operate as a private, early-stage healthcare device company rather than a therapeutics developer, and its business is centered on enabling targeted surgical intervention rather than developing drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cartosense.